Acute Rejection Correlates with Expression of Major Histocompatibility Complex Class I Antigens on Peripheral Blood CD3 + CD8 + T-Lymphocytes following Skin Transplantation in Mice
Free accessResearch articleFirst published online April, 2011
Acute Rejection Correlates with Expression of Major Histocompatibility Complex Class I Antigens on Peripheral Blood CD3 + CD8 + T-Lymphocytes following Skin Transplantation in Mice
This study investigated major histocompatibility complex class I (MHC-I) antigen expression on peripheral blood T-cells after transplantation to assess its potential as an early marker of acute graft rejection (AGR). Using a mouse model with or without immunosuppressive treatment, the expression of MHC-I antigens on CD3+CD8+ T-lymphocytes was assessed by flow cytometry following syngeneic graft (n = 138) or allograft (n = 138) skin transplantation. The occurrence of AGR was assessed by examining the degree of lymphocyte and monocyte infiltration in transplant biopsies. During AGR, expression of MHC-I antigens increased significantly compared with pre-transplant levels in the allograft group, even with immunosuppressive treatment. The highest expression of MHC-I antigens occurred 5 – 6 days before macroscopic rejection. These results suggest that expression of MHC-I antigens on peripheral blood CD3+CD8+ T-lymphocytes could be used as an early marker for predicting AGR.
AlakulppiNSKyllönenLEPartanenJ: Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules. Transplantation2007; 83: 791–798.
2.
MahmoudKOpelzGPelzlS: Evaluation of hepatocyte growth factor as a sensitive marker for early detection of acute renal allograft rejection. Transplantation2007; 83: 1035–1040.
3.
PascualMTheruvathTKawaiT: Strategies to improve long-term outcomes after renal transplantation. N Engl J Med2002; 346: 580–590.
4.
SijpkensYWDoxiadisIIMallatMJ: Early versus late acute rejection episodes in renal transplantation. Transplantation2003; 75: 204–208.
5.
NicholsonMLWheatleyTJDoughmanTM: A prospective randomized trial of three different sizes of core-cutting needle for renal transplant biopsy. Kidney Int2000; 58: 390–395.
6.
SongEChenJSuF: Granzyme B inhibitor I reduces apoptotic cell death of allogeneic-transplanted hepatocytes in spleen. Transplant Proc2001; 33: 3274–3275.
7.
EbataHOikawaIMitoM: Rejection of allogeneic hepatocytes and fetal hepatic tissue transplanted into the rat spleen. Transplantation1985; 39: 221–223.
8.
AshokkumarCGuptaASunQ: Proliferative alloresponse of T cytotoxic cells identifies rejection-prone children with small bowel transplantation. Transplantation2010; 89: 1371–1377.
9.
ZecherDLiQOberbarnscheidtMH: NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8+ T cells. J Immunol2010; 184: 6649–6657.
10.
IssaFSchiopuAWoodKJ: Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol2010; 6: 155–169.
11.
VaessenLMBaanCCOuwehandAJ: Differential avidity and cyclosporine sensitivity of committed donor-specific graft-infiltrating cytotoxic T cells and their precursors. Relevance for clinical cardiac graft rejection. Transplantation1994; 57: 1051–1059.
12.
RoelenDLvan BeelenEvan BreeSP: The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts. Transplantation1995; 59: 1039–1042.
13.
SüsalCOpelzG: Options for immunologic support of renal transplantation through the HLA and immunology laboratories. Am J Transplant2007; 7: 1450–1456.
14.
Ahmed-AnsariATadrosTSKnopfWD: Major histocompatibility complex class I and class II expression by myocytes in cardiac biopsies posttransplantation. Transplantation1988; 45: 972–978.
15.
KimEYLeeENLeeJ: Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation. Exp Mol Med2006; 38: 284–294.
16.
OrlikowskyTWangZDudhaneA: Elevated major histocompatibility complex class I expression protects T cells from antibody- and macrophage-mediated deletion. Immunology1998; 95: 437–442.
17.
WangZQBapatASTrejoV: MHC class I molecules on CD4 T cells regulate receptor-mediated activation signals. Cell Immunol1999; 193: 108–114.
18.
WanFLuNZouX: Expression of MHC-I mRNA in peripheral blood lymphocytes as an early marker of acute rejection following skin transplantation in mice. Tohoku J Exp Med2008; 215: 79–87.
19.
WeinzierlAOLemmelCSchoorO: Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol Cell Proteomics2007; 6: 102–113.
20.
BejaranoPALeviDNassiriM: The pathology of full-thickness cadaver skin transplant for large abdominal defects: A proposed grading system for skin allograft acute rejection. Am J Surg Pathol2004; 28: 670–675.
21.
Le MorvanCCognéMDrouetM: HLA-A and HLA-B transcription decrease with ageing in peripheral blood leucocytes. Clin Exp Immunol2001; 125: 245–250.
22.
Le MorvanCCognéMTroutaudD: Modification of HLA expression on peripheral lymphocytes and monocytes during aging. Mech Ageing Dev1998; 105: 209–220.
23.
FuYNathanDMLiF: Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity. J Clin Invest1993; 91: 2301–2307.
24.
LiXDZouXZhangY: The study of peripheral blood mononuclear cell MHC I and MHC II gene mRNA expression in acute graft rejection. Transplant Proc2006; 38: 3055–3057.
25.
MinguelaAToríoAMarínL: Implication of soluble and membrane HLA class I and serum IL-10 in liver graft acceptance. Hum Immunol1999; 60: 500–509.
26.
Blanco-GarciaRMLópez-AlvarezMRPascual-FigalDA: Expression of HLA molecules on peripheral blood lymphocytes: A useful monitoring parameter in cardiac transplantation. Transplant Proc2007; 39: 2362–2364.
27.
CharreauBCoupelSBouldayG: Cyclosporine inhibits class II major histocompatibility antigen presentation by xenogeneic endothelial cells to human T lymphocytes by altering expression of the class II transcriptional activator gene. Transplantation2000; 70: 354–361.
28.
KimSPoursine-LaurentJTruscottSM: Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature2005; 436: 709–713.
29.
SeligerBRitzUFerroneS: Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int J Cancer2006; 118: 129–138.
30.
GalanteNZCâmaraNOKallasEG: Noninvasive immune monitoring assessed by flow cytometry and real time RT—PCR in urine of renal transplantation recipients. Transpl Immunol2006; 16: 73–80.
